Delivery Order SPE2DB24D1205-SPE2DB25FDASD
- Not listed
- The Defense Logistics Agency awarded a $2,722.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s on September 10, 2025, with an ultimate completion date of September 11, 2025. This contract represents a non-set-aside competitive award for pharmaceutical supplies to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for military and...
- The Defense Logistics Agency awarded a $2,135.94 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units, with a completion date of September 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,418.56 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,586.05 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $1,412.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of August 14, 2025. This non-set-aside competitive award represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,557.69 for Lidocaine 5% Patch (30-count units) on August 19, 2025, with completion targeted for August 20, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $6,124.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 11, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s with a ceiling value of $8,239.83. The contract was competitively awarded without set-aside designation and is scheduled for completion by August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location, fulfilling the pharmaceutical supply needs of the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with a contract value of $2,265.72 and an ultimate completion date of August 6, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a pharmaceutical supply delivery to support federal healthcare needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a $4,131.60 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 3, 2025. This contract reflects a firm fixed price arrangement with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDASDDelivery Order
The Defense Logistics Agency awarded a $30,239.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of September 22, 2025. This non-set-aside contract represents a competitive award to support federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, serving as a key supplier through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.2k | 9/19/25 |